The New Zealand Model is the only method of ending mutations. Contact tracing has to be mandatory to stop virus mutation spread under the current paradigm.
March 8, 2021
By Darcie Moran
The B.1.351 variant of COVID-19 was identified Monday by the Michigan Department of Health and Human Services Bureau of Laboratories today, according to a release late Monday night from the State Emergency Operations Center.
Dr. Joneigh Khaldun, the chief state medical executive, in a statement in the release expressed concern at the discovery, but said it was “not unexpected.”
The latest variant to arrive in Michigan was first detected in October 2020 in South Africa and it shares some mutations with the B.1.1.7 variant, MDHHS noted.
There is controversy as to the effectiveness of existing vaccines and their ability to end variant spread. BE VACCINATED ANYWAY. Being vaccinated will prevent the SARS-CoV-2 virus from mutating further. Continue to practice all measures to end the virus spread, in wearing masks, social distancing, hand hygiene, and eliminate facial touching other than personal hygiene and only after hands are clean.
March 8, 2021
By Alexandra Kelly
Despite the increasing global circulation of COVID-19 vaccines, (click here) the variants of the virus that emerged in late 2020 may disrupt the world’s mission to achieve herd immunity, according to a new study approved for publishing in the journal Nature.
Researchers specifically look at the South African COVID-19 mutation, scientifically dubbed B.1.351, analyzing whether or not these pathogens are more resistant to immune responses prompted by the available vaccines.
Samples of biological fluids, namely convalescent plasma and vaccinee sera, were collected and studied for the volume of COVID-19-neutralizing antibodies contained among volunteers who recovered from a documented COVID-19 infection. This highlights concern for potential reinfection....
March 9, 2021
By Erin Cunningham
The Pfizer-BioNTech coronavirus vaccine (click here) appears to be highly effective against a more contagious variant of the virus first discovered in Brazil, according to a new study published in the New England Journal of Medicine, raising hopes that ongoing vaccination efforts will help curb the variant’s spread.
The study of the vaccine produced by U.S. firm Pfizer and German partner BioNTech was conducted by scientists from the two companies and researchers at the University of Texas Medical Branch. It comes as public health experts warn that the more transmissible variants could drive yet another surge in covid-19 cases, particularly as restrictions are lifted across the United States.
The variant, known as P.1 has spread rapidly across Brazil since emerging in early January, reinfecting people who already had covid, and leaving a tidal wave of misery and death in its wake. According to the U.S. Centers for Disease Control and Prevention, just 15 cases of the Brazil variant have been identified in nine states....
